| Symbol |
Name |
|
A2M
|
alpha-2-macroglobulin
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC8
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACKR3
|
atypical chemokine receptor 3
|
|
ADAD1
|
adenosine deaminase domain containing 1 (testis-specific)
|
|
ADAM10
|
ADAM metallopeptidase domain 10
|
|
ADRA1A
|
adrenoceptor alpha 1A
|
|
ADRA2A
|
adrenoceptor alpha 2A
|
|
ADRA2B
|
adrenoceptor alpha 2B
|
|
ADRA2C
|
adrenoceptor alpha 2C
|
|
AFP
|
alpha-fetoprotein
|
|
AKAP13
|
A kinase (PRKA) anchor protein 13
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ANGPTL3
|
angiopoietin-like 3
|
|
ANXA1
|
annexin A1
|
|
APOBEC3F
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
|
APOBEC3H
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3H
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP2
|
aquaporin 2 (collecting duct)
|
|
AR
|
androgen receptor
|
|
ATF2
|
activating transcription factor 2
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATR
|
ATR serine/threonine kinase
|
|
AURKB
|
aurora kinase B
|
|
AVPR2
|
arginine vasopressin receptor 2
|
|
B2M
|
beta-2-microglobulin
|
|
BACE1
|
beta-site APP-cleaving enzyme 1
|
|
BAX
|
BCL2-associated X protein
|
|
BCHE
|
butyrylcholinesterase
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCL2L12
|
BCL2-like 12 (proline rich)
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BMF
|
Bcl2 modifying factor
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BMP7
|
bone morphogenetic protein 7
|
|
BOP1
|
block of proliferation 1
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRD4
|
bromodomain containing 4
|
|
BST2
|
bone marrow stromal cell antigen 2
|
|
BTRC
|
beta-transducin repeat containing E3 ubiquitin protein ligase
|
|
C2ORF40
|
chromosome 2 open reading frame 40
|
|
C3
|
complement component 3
|
|
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit
|
|
CACNA1D
|
calcium channel, voltage-dependent, L type, alpha 1D subunit
|
|
CACNA1H
|
calcium channel, voltage-dependent, T type, alpha 1H subunit
|
|
CALHM1
|
calcium homeostasis modulator 1
|
|
CALR
|
calreticulin
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CCKBR
|
cholecystokinin B receptor
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL22
|
chemokine (C-C motif) ligand 22
|
|
CCL26
|
chemokine (C-C motif) ligand 26
|
|
CCNA2
|
cyclin A2
|
|
CCNB1
|
cyclin B1
|
|
CCND1
|
cyclin D1
|
|
CCND3
|
cyclin D3
|
|
CCNE1
|
cyclin E1
|
|
CD1A
|
CD1a molecule
|
|
CD209
|
CD209 molecule
|
|
CD244
|
CD244 molecule, natural killer cell receptor 2B4
|
|
CD3D
|
CD3d molecule, delta (CD3-TCR complex)
|
|
CD40LG
|
CD40 ligand
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD47
|
CD47 molecule
|
|
CD63
|
CD63 molecule
|
|
CD82
|
CD82 molecule
|
|
CD9
|
CD9 molecule
|
|
CDC20
|
cell division cycle 20
|
|
CDC25B
|
cell division cycle 25B
|
|
CDC25C
|
cell division cycle 25C
|
|
CDH13
|
cadherin 13
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDK6
|
cyclin-dependent kinase 6
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDR2
|
cerebellar degeneration-related protein 2, 62kDa
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEBPE
|
CCAAT/enhancer binding protein (C/EBP), epsilon
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHRNA7
|
cholinergic receptor, nicotinic, alpha 7 (neuronal)
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CKMT1B
|
creatine kinase, mitochondrial 1B
|
|
CLCN1
|
chloride channel, voltage-sensitive 1
|
|
CLCN5
|
chloride channel, voltage-sensitive 5
|
|
CLEC16A
|
C-type lectin domain family 16, member A
|
|
CLEC1B
|
C-type lectin domain family 1, member B
|
|
CLN6
|
ceroid-lipofuscinosis, neuronal 6, late infantile, variant
|
|
CR2
|
complement component (3d/Epstein Barr virus) receptor 2
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREB3L1
|
cAMP responsive element binding protein 3-like 1
|
|
CREBBP
|
CREB binding protein
|
|
CRHBP
|
corticotropin releasing hormone binding protein
|
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
|
CRYAB
|
crystallin, alpha B
|
|
CRYGS
|
crystallin, gamma S
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CSF2RB
|
colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage)
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTR9
|
CTR9, Paf1/RNA polymerase II complex component
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DAXX
|
death-domain associated protein
|
|
DCLRE1C
|
DNA cross-link repair 1C
|
|
DCTN1
|
dynactin 1
|
|
DEFA1
|
defensin, alpha 1
|
|
DEFA5
|
defensin, alpha 5, Paneth cell-specific
|
|
DES
|
desmin
|
|
DIRAS3
|
DIRAS family, GTP-binding RAS-like 3
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
DROSHA
|
drosha, ribonuclease type III
|
|
DUX4L1
|
double homeobox 4 like 1
|
|
E2F1
|
E2F transcription factor 1
|
|
E4F1
|
E4F transcription factor 1
|
|
EDN1
|
endothelin 1
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGLN3
|
egl-9 family hypoxia-inducible factor 3
|
|
EGR1
|
early growth response 1
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
|
EP300
|
E1A binding protein p300
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERH
|
enhancer of rudimentary homolog (Drosophila)
|
|
ETV6
|
ets variant 6
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FASN
|
fatty acid synthase
|
|
FBXO5
|
F-box protein 5
|
|
FCAR
|
Fc fragment of IgA receptor
|
|
FCP1
|
F-cell production 1
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR4
|
fibroblast growth factor receptor 4
|
|
FHIT
|
fragile histidine triad
|
|
FHL2
|
four and a half LIM domains 2
|
|
FKRP
|
fukutin related protein
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FMR1
|
fragile X mental retardation 1
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FSHR
|
follicle stimulating hormone receptor
|
|
FTO
|
fat mass and obesity associated
|
|
FXN
|
frataxin
|
|
GABRA2
|
gamma-aminobutyric acid (GABA) A receptor, alpha 2
|
|
GABRG1
|
gamma-aminobutyric acid (GABA) A receptor, gamma 1
|
|
GADD45B
|
growth arrest and DNA-damage-inducible, beta
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GBF1
|
golgi brefeldin A resistant guanine nucleotide exchange factor 1
|
|
GCLC
|
glutamate-cysteine ligase, catalytic subunit
|
|
GFI1
|
growth factor independent 1 transcription repressor
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GLI1
|
GLI family zinc finger 1
|
|
GNMT
|
glycine N-methyltransferase
|
|
GPC3
|
glypican 3
|
|
GRIA3
|
glutamate receptor, ionotropic, AMPA 3
|
|
GRIK2
|
glutamate receptor, ionotropic, kainate 2
|
|
HAVCR1
|
hepatitis A virus cellular receptor 1
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
|
HBB
|
hemoglobin, beta
|
|
HBEGF
|
heparin-binding EGF-like growth factor
|
|
HCN4
|
hyperpolarization activated cyclic nucleotide gated potassium channel 4
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMGB1
|
high mobility group box 1
|
|
HMGN3
|
high mobility group nucleosomal binding domain 3
|
|
HNRNPC
|
heterogeneous nuclear ribonucleoprotein C (C1/C2)
|
|
HPSE
|
heparanase
|
|
HR
|
hair growth associated
|
|
HRH4
|
histamine receptor H4
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSPA1A
|
heat shock 70kDa protein 1A
|
|
HSPB7
|
heat shock 27kDa protein family, member 7 (cardiovascular)
|
|
HSPB8
|
heat shock 22kDa protein 8
|
|
HTT
|
huntingtin
|
|
ICOS
|
inducible T-cell co-stimulator
|
|
IDDM8
|
insulin-dependent diabetes mellitus 8
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IFI16
|
interferon, gamma-inducible protein 16
|
|
IFIH1
|
interferon induced with helicase C domain 1
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNA2
|
interferon, alpha 2
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IFNG
|
interferon, gamma
|
|
IFNL3
|
interferon, lambda 3
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2R
|
insulin-like growth factor 2 receptor
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGFBP7
|
insulin-like growth factor binding protein 7
|
|
IK
|
IK cytokine, down-regulator of HLA II
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IL12B
|
interleukin 12B
|
|
IL15
|
interleukin 15
|
|
IL1A
|
interleukin 1, alpha
|
|
IL2
|
interleukin 2
|
|
IL21
|
interleukin 21
|
|
IL27
|
interleukin 27
|
|
IL27RA
|
interleukin 27 receptor, alpha
|
|
IL3RA
|
interleukin 3 receptor, alpha (low affinity)
|
|
IL6
|
interleukin 6
|
|
IL7
|
interleukin 7
|
|
INPP4B
|
inositol polyphosphate-4-phosphatase, type II, 105kDa
|
|
IRAK1
|
interleukin-1 receptor-associated kinase 1
|
|
IRF3
|
interferon regulatory factor 3
|
|
IRF7
|
interferon regulatory factor 7
|
|
IRF8
|
interferon regulatory factor 8
|
|
IRS1
|
insulin receptor substrate 1
|
|
ITGA1
|
integrin, alpha 1
|
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
JAK1
|
Janus kinase 1
|
|
KAT2B
|
K(lysine) acetyltransferase 2B
|
|
KCNA5
|
potassium channel, voltage gated shaker related subfamily A, member 5
|
|
KCNA7
|
potassium channel, voltage gated shaker related subfamily A, member 7
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNJ2
|
potassium channel, inwardly rectifying subfamily J, member 2
|
|
KCNJ3
|
potassium channel, inwardly rectifying subfamily J, member 3
|
|
KCNK9
|
potassium channel, two pore domain subfamily K, member 9
|
|
KCNN3
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 3
|
|
KDM1A
|
lysine (K)-specific demethylase 1A
|
|
KDM2A
|
lysine (K)-specific demethylase 2A
|
|
KDM6B
|
lysine (K)-specific demethylase 6B
|
|
KDR
|
kinase insert domain receptor
|
|
KIAA1109
|
KIAA1109
|
|
KIR2DL1
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1
|
|
KIR2DL4
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4
|
|
KNG1
|
kininogen 1
|
|
LARS
|
leucyl-tRNA synthetase
|
|
LIG4
|
ligase IV, DNA, ATP-dependent
|
|
LIN28A
|
lin-28 homolog A (C. elegans)
|
|
LINGO1
|
leucine rich repeat and Ig domain containing 1
|
|
LMNA
|
lamin A/C
|
|
LPA
|
lipoprotein, Lp(a)
|
|
LRP8
|
low density lipoprotein receptor-related protein 8, apolipoprotein e receptor
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LRRTM3
|
leucine rich repeat transmembrane neuronal 3
|
|
LTA
|
lymphotoxin alpha
|
|
LTF
|
lactotransferrin
|
|
MAD2L1
|
MAD2 mitotic arrest deficient-like 1 (yeast)
|
|
MAD2L1BP
|
MAD2L1 binding protein
|
|
MAML2
|
mastermind-like 2 (Drosophila)
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K7
|
mitogen-activated protein kinase kinase 7
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MARVELD2
|
MARVEL domain containing 2
|
|
MAT2A
|
methionine adenosyltransferase II, alpha
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MDM4
|
MDM4, p53 regulator
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR10A
|
microRNA 10a
|
|
MIR29C
|
microRNA 29c
|
|
MKNK1
|
MAP kinase interacting serine/threonine kinase 1
|
|
MLLT10
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MN1
|
meningioma (disrupted in balanced translocation) 1
|
|
MOG
|
myelin oligodendrocyte glycoprotein
|
|
MPO
|
myeloperoxidase
|
|
MTDH
|
metadherin
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTR
|
5-methyltetrahydrofolate-homocysteine methyltransferase
|
|
MXD4
|
MAX dimerization protein 4
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
NDUFA13
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13
|
|
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
|
|
NFATC2
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NGB
|
neuroglobin
|
|
NKAPL
|
NFKB activating protein-like
|
|
NKX2-5
|
NK2 homeobox 5
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOTCH4
|
notch 4
|
|
NOX1
|
NADPH oxidase 1
|
|
NPPB
|
natriuretic peptide B
|
|
NPSR1
|
neuropeptide S receptor 1
|
|
NR1D1
|
nuclear receptor subfamily 1, group D, member 1
|
|
NR1I3
|
nuclear receptor subfamily 1, group I, member 3
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2
|
|
NRG1
|
neuregulin 1
|
|
NRP1
|
neuropilin 1
|
|
NUTM1
|
NUT midline carcinoma, family member 1
|
|
NXF5
|
nuclear RNA export factor 5
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
P2RX1
|
purinergic receptor P2X, ligand gated ion channel, 1
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
PANX1
|
pannexin 1
|
|
PAX5
|
paired box 5
|
|
PCBP1
|
poly(rC) binding protein 1
|
|
PCBP2
|
poly(rC) binding protein 2
|
|
PDCD6IP
|
programmed cell death 6 interacting protein
|
|
PDE4A
|
phosphodiesterase 4A, cAMP-specific
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PEBP1
|
phosphatidylethanolamine binding protein 1
|
|
PEG3
|
paternally expressed 3
|
|
PGF
|
placental growth factor
|
|
PHB
|
prohibitin
|
|
PIAS1
|
protein inhibitor of activated STAT, 1
|
|
PICALM
|
phosphatidylinositol binding clathrin assembly protein
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIP
|
prolactin-induced protein
|
|
PKD1
|
polycystic kidney disease 1 (autosomal dominant)
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
PLAC1
|
placenta-specific 1
|
|
PLD3
|
phospholipase D family, member 3
|
|
PLVAP
|
plasmalemma vesicle associated protein
|
|
PLXNB1
|
plexin B1
|
|
PML
|
promyelocytic leukemia
|
|
POT1
|
protection of telomeres 1
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPP2R2A
|
protein phosphatase 2, regulatory subunit B, alpha
|
|
PRDX1
|
peroxiredoxin 1
|
|
PRIMPOL
|
primase and polymerase (DNA-directed)
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCE
|
protein kinase C, epsilon
|
|
PRKG2
|
protein kinase, cGMP-dependent, type II
|
|
PRKRA
|
protein kinase, interferon-inducible double stranded RNA dependent activator
|
|
PRNP
|
prion protein
|
|
PRPF8
|
pre-mRNA processing factor 8
|
|
PSEN1
|
presenilin 1
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
PTPRA
|
protein tyrosine phosphatase, receptor type, A
|
|
PVRL1
|
poliovirus receptor-related 1 (herpesvirus entry mediator C)
|
|
PXN
|
paxillin
|
|
RAB1A
|
RAB1A, member RAS oncogene family
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAD17
|
RAD17 homolog (S. pombe)
|
|
RAD9B
|
RAD9 homolog B (S. pombe)
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RASGRP1
|
RAS guanyl releasing protein 1 (calcium and DAG-regulated)
|
|
RB1
|
retinoblastoma 1
|
|
RBFOX1
|
RNA binding protein, fox-1 homolog (C. elegans) 1
|
|
RBFOX2
|
RNA binding protein, fox-1 homolog (C. elegans) 2
|
|
RCOR1
|
REST corepressor 1
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
REM1
|
RAS (RAD and GEM)-like GTP-binding 1
|
|
RFX1
|
regulatory factor X, 1 (influences HLA class II expression)
|
|
RGS7BP
|
regulator of G-protein signaling 7 binding protein
|
|
RNR2
|
RNA, ribosomal cluster 2
|
|
ROCK2
|
Rho-associated, coiled-coil containing protein kinase 2
|
|
RPA2
|
replication protein A2, 32kDa
|
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX2
|
runt-related transcription factor 2
|
|
S100B
|
S100 calcium binding protein B
|
|
SAMHD1
|
SAM domain and HD domain 1
|
|
SAR1A
|
secretion associated, Ras related GTPase 1A
|
|
SCGB2A2
|
secretoglobin, family 2A, member 2
|
|
SCN4A
|
sodium channel, voltage gated, type IV alpha subunit
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SCN9A
|
sodium channel, voltage gated, type IX alpha subunit
|
|
SDHA
|
succinate dehydrogenase complex, subunit A, flavoprotein (Fp)
|
|
SDHB
|
succinate dehydrogenase complex, subunit B, iron sulfur (Ip)
|
|
SEC24C
|
SEC24 family member C
|
|
SELPLG
|
selectin P ligand
|
|
SEMA3A
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A
|
|
SERPINC1
|
serpin peptidase inhibitor, clade C (antithrombin), member 1
|
|
SERPINE2
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
|
SFTPA1
|
surfactant protein A1
|
|
SHH
|
sonic hedgehog
|
|
SIAH1
|
siah E3 ubiquitin protein ligase 1
|
|
SIRPA
|
signal-regulatory protein alpha
|
|
SKI
|
SKI proto-oncogene
|
|
SLC2A4
|
solute carrier family 2 (facilitated glucose transporter), member 4
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLCO1B1
|
solute carrier organic anion transporter family, member 1B1
|
|
SMAD1
|
SMAD family member 1
|
|
SMAD2
|
SMAD family member 2
|
|
SMAD4
|
SMAD family member 4
|
|
SMURF2
|
SMAD specific E3 ubiquitin protein ligase 2
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SND1
|
staphylococcal nuclease and tudor domain containing 1
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SOCS7
|
suppressor of cytokine signaling 7
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SPHK1
|
sphingosine kinase 1
|
|
SPI1
|
Spi-1 proto-oncogene
|
|
SPINT2
|
serine peptidase inhibitor, Kunitz type, 2
|
|
SPRED1
|
sprouty-related, EVH1 domain containing 1
|
|
SPRED2
|
sprouty-related, EVH1 domain containing 2
|
|
SPRY2
|
sprouty homolog 2 (Drosophila)
|
|
SRA1
|
steroid receptor RNA activator 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SSBP2
|
single-stranded DNA binding protein 2
|
|
STAP2
|
signal transducing adaptor family member 2
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
STUB1
|
STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase
|
|
SUMO1
|
small ubiquitin-like modifier 1
|
|
TAF5L
|
TAF5-like RNA polymerase II, p300/CBP-associated factor (PCAF)-associated factor, 65kDa
|
|
TBRG4
|
transforming growth factor beta regulator 4
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TGM2
|
transglutaminase 2
|
|
THRB
|
thyroid hormone receptor, beta
|
|
TICAM1
|
toll-like receptor adaptor molecule 1
|
|
TIMD4
|
T-cell immunoglobulin and mucin domain containing 4
|
|
TLK1
|
tousled-like kinase 1
|
|
TLN1
|
talin 1
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR5
|
toll-like receptor 5
|
|
TLR7
|
toll-like receptor 7
|
|
TLR9
|
toll-like receptor 9
|
|
TMPRSS11A
|
transmembrane protease, serine 11A
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF11A
|
tumor necrosis factor receptor superfamily, member 11a, NFKB activator
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TOP1
|
topoisomerase (DNA) I
|
|
TP53
|
tumor protein p53
|
|
TP73
|
tumor protein p73
|
|
TPH1
|
tryptophan hydroxylase 1
|
|
TPH2
|
tryptophan hydroxylase 2
|
|
TPP1
|
tripeptidyl peptidase I
|
|
TPPP
|
tubulin polymerization promoting protein
|
|
TRAF2
|
TNF receptor-associated factor 2
|
|
TRAF3
|
TNF receptor-associated factor 3
|
|
TREM1
|
triggering receptor expressed on myeloid cells 1
|
|
TRIM21
|
tripartite motif containing 21
|
|
TRIM5
|
tripartite motif containing 5
|
|
TROVE2
|
TROVE domain family, member 2
|
|
TRPM2
|
transient receptor potential cation channel, subfamily M, member 2
|
|
TRPM4
|
transient receptor potential cation channel, subfamily M, member 4
|
|
TRPM5
|
transient receptor potential cation channel, subfamily M, member 5
|
|
TRPM7
|
transient receptor potential cation channel, subfamily M, member 7
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
|
TRPV4
|
transient receptor potential cation channel, subfamily V, member 4
|
|
TXN
|
thioredoxin
|
|
UBE3A
|
ubiquitin protein ligase E3A
|
|
UBXN6
|
UBX domain protein 6
|
|
UNC13A
|
unc-13 homolog A (C. elegans)
|
|
USF1
|
upstream transcription factor 1
|
|
USF2
|
upstream transcription factor 2, c-fos interacting
|
|
USP17L2
|
ubiquitin specific peptidase 17-like family member 2
|
|
VAPB
|
VAMP (vesicle-associated membrane protein)-associated protein B and C
|
|
VCL
|
vinculin
|
|
VCP
|
valosin containing protein
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VLDLR
|
very low density lipoprotein receptor
|
|
VRK1
|
vaccinia related kinase 1
|
|
VWF
|
von Willebrand factor
|
|
WASL
|
Wiskott-Aldrich syndrome-like
|
|
WFS1
|
Wolfram syndrome 1 (wolframin)
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XPA
|
xeroderma pigmentosum, complementation group A
|
|
XPO1
|
exportin 1
|
|
XRCC4
|
X-ray repair complementing defective repair in Chinese hamster cells 4
|
|
YBX3
|
Y box binding protein 3
|
|
ZBTB17
|
zinc finger and BTB domain containing 17
|
|
ZDHHC17
|
zinc finger, DHHC-type containing 17
|
|
ZFX
|
zinc finger protein, X-linked
|
